908 Devices (NASDAQ:MASS) Director Christopher Brown Sells 9,900 Shares

908 Devices Inc. (NASDAQ:MASS) Director Christopher Brown sold 9,900 shares of the business’s stock in a transaction on Tuesday, June 23rd. The stock was sold at an average price of $9.04, for a total value of $89,496.00. Following the completion of the transaction, the director directly owned 865,559 shares in the company, valued at approximately $7,824,653.36. This represents a 1.13% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Stock Up 0.1%

Shares of NASDAQ:MASS opened at $8.98 on Friday. The firm has a market cap of $339.53 million, a P/E ratio of -8.98 and a beta of 0.63. 908 Devices Inc. has a 12 month low of $5.03 and a 12 month high of $9.34. The company’s 50-day moving average price is $7.81 and its two-hundred day moving average price is $6.78.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Weiss Ratings lowered 908 Devices from a “hold (c-)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. Wall Street Zen lowered 908 Devices from a “buy” rating to a “hold” rating in a research report on Sunday, June 14th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, 908 Devices presently has an average rating of “Hold” and an average price target of $12.00.

Institutional Investors Weigh In On 908 Devices

A number of institutional investors have recently made changes to their positions in MASS. First Light Asset Management LLC increased its stake in shares of 908 Devices by 92.6% in the 4th quarter. First Light Asset Management LLC now owns 4,836,186 shares of the company’s stock valued at $25,390,000 after acquiring an additional 2,325,690 shares during the last quarter. Granahan Investment Management LLC increased its stake in 908 Devices by 662.6% in the first quarter. Granahan Investment Management LLC now owns 695,070 shares of the company’s stock valued at $4,254,000 after purchasing an additional 603,929 shares in the last quarter. Needham Investment Management LLC increased its stake in 908 Devices by 246.8% in the fourth quarter. Needham Investment Management LLC now owns 770,000 shares of the company’s stock valued at $4,042,000 after purchasing an additional 548,000 shares in the last quarter. Marshall Wace LLP raised its holdings in 908 Devices by 359.4% in the second quarter. Marshall Wace LLP now owns 648,796 shares of the company’s stock worth $4,626,000 after purchasing an additional 507,562 shares during the period. Finally, First Eagle Investment Management LLC boosted its position in shares of 908 Devices by 125.9% during the third quarter. First Eagle Investment Management LLC now owns 603,962 shares of the company’s stock worth $5,291,000 after purchasing an additional 336,584 shares in the last quarter. 88.06% of the stock is owned by institutional investors and hedge funds.

908 Devices Company Profile

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.